Loading...
The University of Chicago Header Logo
Keywords
Last Name
Institution

Connection

Search Results to Stanley Liauw

This is a "connection" page, showing the details of why an item matched the keywords from your search.

                     
                     

One or more keywords matched the following properties of Liauw, Stanley

PropertyValue
overview Dr. Stanley Liauw serves as the Director of Clinical Operations and is the clinical lead for the genitourinary (GU) cancer program and the gastrointestinal (GI) cancer program within the Department of Radiation and Cellular Oncology at the University of Chicago. In the past 10 years on faculty, Dr. Liauw has developed research programs in these disease sites, with an interest in outcomes research and clinical trials. The central mission of his research is to conduct clinical studies to define current clinical outcomes and areas of need, develop hypotheses, and test novel regimens to reduce the morbidity or mortality of radiation therapy in the treatment of cancer. A major focus of Dr. Liauw's efforts include the periodic analysis and reporting of cancer outcomes with radiation therapy. This work, derived from multiple institutional databases of more than 2000 patients, has resulted in numerous abstract presentations and publications in peer-reviewed journals such as Journal of Clinical Oncology, International Journal of Radiation Oncology, Biology, Physics and Cancer. These contributions generally fall into 3 categories of interest: presenting hypotheses to improve the therapeutic ratio of therapy, studying the use of imaging in radiation oncology, and exploring potential markers of response to therapy. A number of clinical protocols have been opened for patients with genitourinary and gastrointestinal cancers. Dr. Liauw has investigated and initiated trials for a: phase I study of dose escalated stereotactic body RT trial for unresectable pancreatic cancer, phase II quality of life study of oral hormonal therapy with RT for prostate cancer, phase I study for oligometastatic renal cell cancer, and phase I randomized study for hepatocellular carcinoma treated with RT and immunotherapy. Outside of his research interests, Dr. Liauw has overseen several intradepartmental projects aimed at improving clinical workflow and patient safety, with potential downstream effects on patient and employee satisfaction. He served as the clinical lead for the implementation of intraoperative radiation therapy in 2015, as an Associate Editor for GI cancers for the International Journal of Radiation Oncology, Biology, and Physics, as an examiner and question writer for the American Board of Radiology for GU cancers, and an invited speaker for national and international educational lectures such as through the American Society of Radiation Oncology (ASTRO) and the American Urological Association. He has been an invited Visiting Professor for resident education at multiple institutions, and has been regularly recognized from the University of Chicago training program as a top educator. He has been an ad hoc reviewer of manuscripts for more than 20 scientific journals, including Journal of Clinical Oncology and the New England Journal of Medicine.

One or more keywords matched the following items that are connected to Liauw, Stanley

Item TypeName
Concept Prostatic Neoplasms
Academic Article Salvage radiotherapy for recurrent prostate cancer after radical prostatectomy.
Academic Article Second malignancies after prostate brachytherapy: incidence of bladder and colorectal cancers in patients with 15 years of potential follow-up.
Academic Article Grade migration in prostate cancer: an analysis using the Surveillance, Epidemiology, and End Results registry.
Academic Article External beam radiotherapy for prostate cancer patients on anticoagulation therapy: how significant is the bleeding toxicity?
Academic Article Dose-escalated radiation therapy for intermediate-risk prostate cancer: patient selection for androgen deprivation therapy using percentage of positive cores.
Academic Article Prostate-specific antigen halving time while on neoadjuvant androgen deprivation therapy is associated with biochemical control in men treated with radiation therapy for localized prostate cancer.
Academic Article Dose-escalated radiotherapy for high-risk prostate cancer: outcomes in modern era with short-term androgen deprivation therapy.
Academic Article The use of anticoagulants improves biochemical control of localized prostate cancer treated with radiotherapy.
Academic Article Radiotherapeutic strategies in the management of low-risk prostate cancer.
Academic Article Statin use and risk of prostate cancer recurrence in men treated with radiation therapy.
Academic Article Late rectal toxicity after prostate brachytherapy: influence of supplemental external beam radiation on dose-volume histogram analysis.
Academic Article Predicting the outcome of salvage radiation therapy for recurrent prostate cancer after radical prostatectomy.
Academic Article Salvage radiotherapy after postprostatectomy biochemical failure: does pretreatment radioimmunoscintigraphy help select patients with locally confined disease?
Academic Article Aspirin use and the risk of prostate cancer mortality in men treated with prostatectomy or radiotherapy.
Academic Article A surveillance, epidemiology, and end results registry analysis of prostate cancer modality time trends by age.
Academic Article Age and grade trends in prostate cancer (1974-2003): a Surveillance, Epidemiology, and End Results Registry analysis.
Academic Article Biochemical control and toxicity after intensity-modulated radiation therapy for prostate cancer.
Academic Article External beam radiation therapy after transurethral resection of the prostate: a report on acute and late genitourinary toxicity.
Academic Article External beam radiotherapy for prostate cancer: urinary outcomes for men with high International Prostate Symptom Scores (IPSS).
Academic Article High-dose radiotherapy with or without androgen deprivation therapy for intermediate-risk prostate cancer: cancer control and toxicity outcomes.
Academic Article Prolongation of total treatment time because of infrequently missed days of treatment is not associated with inferior biochemical outcome after dose-escalated radiation therapy for prostate cancer.
Academic Article Late toxicity after intensity-modulated radiation therapy for localized prostate cancer: an exploration of dose-volume histogram parameters to limit genitourinary and gastrointestinal toxicity.
Academic Article Salvage radiotherapy for biochemical failure of radical prostatectomy: a single-institution experience.
Academic Article The role of indium-111 radioimmunoscintigraphy in post-radical retropubic prostatectomy management of prostate cancer patients.
Academic Article A multi-institutional matched-control analysis of adjuvant and salvage postoperative radiation therapy for pT3-4N0 prostate cancer.
Academic Article Prostate cancer modality time trend analyses from 1973 to 2004: a Surveillance, Epidemiology, and End Results registry analysis.
Academic Article Image-guided radiotherapy using surgical clips as fiducial markers after prostatectomy: a report of total setup error, required PTV expansion, and dosimetric implications.
Academic Article Validation of normal tissue complication probability predictions in individual patient: late rectal toxicity.
Academic Article Evaluation of the prostate bed for local recurrence after radical prostatectomy using endorectal magnetic resonance imaging.
Academic Article Effects of aspirin on cancer initiation and progression.
Academic Article Toxicity after external beam radiotherapy for prostate cancer: an analysis of late morbidity in men with diabetes mellitus.
Academic Article Tobacco use and external beam radiation therapy for prostate cancer: Influence on biochemical control and late toxicity.
Academic Article The impact of hormonal therapy on sexual quality of life in men receiving intensity modulated radiation therapy for prostate cancer.
Academic Article Role of HMG-CoA reductase inhibitors with curative radiotherapy in men with prostate cancer.
Academic Article Late toxicity and quality of life after definitive treatment of prostate cancer: redefining optimal rectal sparing constraints for intensity-modulated radiation therapy.
Academic Article Impact of magnetic resonance imaging on computed tomography-based treatment planning and acute toxicity for prostate cancer patients treated with intensity modulated radiation therapy.
Academic Article Image-guided radiation therapy for prostate cancer: A computed tomography-based assessment of fiducial marker migration between placement and 7 days.
Academic Article Quality of Life after Post-Prostatectomy Intensity Modulated Radiation Therapy: Pelvic Nodal Irradiation Is Not Associated with Worse Bladder, Bowel, or Sexual Outcomes.
Academic Article A Prostate Fossa Contouring Instructional Module: Implementation and Evaluation.
Academic Article Endorectal MRI for risk classification of localized prostate cancer: Radiographic findings and influence on treatment decisions.
Academic Article Bladder dose-volume parameters are associated with urinary incontinence after postoperative intensity modulated radiation therapy for prostate cancer.
Academic Article Salvage Radiation Therapy Dose Response for Biochemical Failure of Prostate Cancer After Prostatectomy-A Multi-Institutional Observational Study.
Academic Article ACR appropriateness criteria: Permanent source brachytherapy for prostate cancer.
Academic Article ACR Appropriateness Criteria® Locally Advanced, High-Risk Prostate Cancer.
Academic Article High-risk Prostate Cancer Treated With Dose-escalated RT: An Analysis of Hormonal Therapy Use and Duration, and Prognostic Implications of PSA Nadir =0.2 to Select Men for Short-term Hormonal Therapy.
Academic Article Long-term Outcome of Prostate Cancer Patients Who Exhibit Biochemical Failure Despite Salvage Radiation Therapy After Radical Prostatectomy.
Academic Article The use of Hormonal Therapy to Augment Radiation Therapy in Prostate Cancer: An Update.
Academic Article Contemporary management of men with high-risk localized prostate cancer in the United States.
Academic Article Managing Cancer Relapse After Radical Prostatectomy: Adjuvant Versus Salvage Radiation Therapy.
Academic Article Comparison Between Adjuvant and Early-Salvage Postprostatectomy Radiotherapy for Prostate Cancer With Adverse Pathological Features.
Academic Article ACR Appropriateness Criteria® external beam radiation therapy treatment planning for clinically localized prostate cancer, part I of II.
Academic Article Pretreatment multiparametric MRI is independently associated with biochemical outcome in men treated with radiation therapy for prostate cancer.
Academic Article ACR Appropriateness Criteria for external beam radiation therapy treatment planning for clinically localized prostate cancer, part II of II.
Academic Article Contemporary management of men with high-risk localized prostate cancer in the United States.
Academic Article Multi-institutional Evaluation of Elective Nodal Irradiation and/or Androgen Deprivation Therapy with Postprostatectomy Salvage Radiotherapy for Prostate Cancer.
Academic Article Application of a Prognostic Stratification System for High-risk Prostate Cancer to Patients Treated With Radiotherapy: Implications for Treatment Optimization.
Academic Article A phase II randomized placebo-controlled double-blind study of salvage radiation therapy plus placebo versus SRT plus enzalutamide with high-risk PSA-recurrent prostate cancer after radical prostatectomy (SALV-ENZA).
Academic Article Prostate Cancer Outcomes Following Solid-Organ Transplantation: A SEER-Medicare Analysis.
Academic Article PI-RADS score is associated with biochemical control and distant metastasis in men with intermediate-risk and high-risk prostate cancer treated with radiation therapy.
Academic Article Improved outcomes after radiotherapy for prostate cancer: Anticoagulation, antiplatelet therapy, and platelet count as key factors in disease progression.
Academic Article 18F-Fluciclovine Positron Emission Tomography in Men With Biochemical Recurrence of Prostate Cancer After Radical Prostatectomy and Planning to Undergo Salvage Radiation Therapy: Results from LOCATE.

Search Criteria
  • Prostate Cancer